The potential cost-effectiveness of HPV vaccination among girls in Mongolia

20224 citationsJournal Articlegold Open Access

Authors

Munkh-Erdene Luvsan · Mongolian National University of Medical Sciences

Elisabeth Vodicka · Program for Appropriate Technology in Health

Uranbolor Jugder · National Center for Communicable Diseases

Undarmaa Tudev · National Center for Communicable Diseases

Andrew R. Clark · London School of Hygiene & Tropical Medicine

Devin Groman · Program for Appropriate Technology in Health

Abstract

HPV vaccination among girls is highly likely to be a cost-effective investment in Mongolia compared to no vaccination with projected ICERs less than 20% of the 2018 GDP per capita of $3,735.

Topics & Keywords

Cervical Cancer and HPV Research Vaccine Coverage and Hesitancy Hepatitis B Virus Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Vaccine X

Volume 11, pp. 100161-100161

DOI: 10.1016/j.jvacx.2022.100161

Field-Weighted Citation Impact: 0.62